Morepen Hits Record Q2 Revenue of ₹755 Crore as CDMO Scales Up; EBITDA Jumps 273%
Morepen Laboratories reported Q2 FY27 revenue of ₹755 crore, up 81%, and EBITDA of ₹132 crore, up 273%, as its CDMO business hit commercial scale, exports more than doubled and it filed its first US ANDA.
